These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 2841961

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro antitumor activity of mitomycin C derivative (RM-49) and new anticancer antibiotics (FK973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay.
    Horiuchi N, Nakagawa K, Sasaki Y, Minato K, Fujiwara Y, Nezu K, Ohe Y, Saijo N.
    Cancer Chemother Pharmacol; 1988; 22(3):246-50. PubMed ID: 2842080
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Determinants of CPT-11 and SN-38 activities in human lung cancer cells.
    van Ark-Otte J, Kedde MA, van der Vijgh WJ, Dingemans AM, Jansen WJ, Pinedo HM, Boven E, Giaccone G.
    Br J Cancer; 1998 Jun; 77(12):2171-6. PubMed ID: 9649129
    [Abstract] [Full Text] [Related]

  • 6. Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay.
    Hida T, Ueda R, Takahashi T, Watanabe H, Kato T, Suyama M, Sugiura T, Ariyoshi Y, Takahashi T.
    Cancer Res; 1989 Sep 01; 49(17):4785-90. PubMed ID: 2547517
    [Abstract] [Full Text] [Related]

  • 7. In vitro chemosensitivity testing of human non-small cell lung cancer cell lines.
    Bepler G, O'Briant K.
    Anticancer Res; 1998 Sep 01; 18(5A):3181-5. PubMed ID: 9858881
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the relative cytotoxic effects of anticancer agents in serum-supplemented versus serum-free media using a tetrazolium colorimetric assay.
    Tsai CM, Perng RP, Chang KT, Venzon D, Gazdar AF.
    Jpn J Cancer Res; 1996 Jan 01; 87(1):91-7. PubMed ID: 8609055
    [Abstract] [Full Text] [Related]

  • 9. Basis for experimental chemotherapy in lung cancer.
    Sadler JG, Natale RB.
    Semin Oncol; 1988 Dec 01; 15(6 Suppl 7):32-6. PubMed ID: 2851175
    [Abstract] [Full Text] [Related]

  • 10. Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines.
    Gazdar AF, Kadoyama C, Venzon D, Park JG, Tsai CM, Linnoila RI, Mulshine JL, Ihde DC, Giaccone G.
    J Natl Cancer Inst Monogr; 1992 Dec 01; (13):191-6. PubMed ID: 1327032
    [Abstract] [Full Text] [Related]

  • 11. Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity.
    Jensen PB, Roed H, Sehested M, Demant EJ, Vindeløv L, Christensen IJ, Hansen HH.
    Cancer Chemother Pharmacol; 1992 Dec 01; 31(1):46-52. PubMed ID: 1360876
    [Abstract] [Full Text] [Related]

  • 12. Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines?
    Campling BG, Baer K, Baker HM, Lam YM, Cole SP.
    Br J Cancer; 1993 Aug 01; 68(2):327-35. PubMed ID: 8102244
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia.
    Pieters R, Huismans DR, Leyva A, Veerman AJ.
    Br J Cancer; 1989 Feb 01; 59(2):217-20. PubMed ID: 2930687
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of chemosensitivity tests: clonogenic assay versus MTT assay.
    Kawada K, Yonei T, Ueoka H, Kiura K, Tabata M, Takigawa N, Harada M, Tanimoto M.
    Acta Med Okayama; 2002 Jun 01; 56(3):129-34. PubMed ID: 12108583
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.
    Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB.
    Cancer Res; 1987 Feb 15; 47(4):936-42. PubMed ID: 3802100
    [Abstract] [Full Text] [Related]

  • 16. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F, Livartowski A, De Cremoux P, Bourgeois Y, Arvelo F, Pouillart P, Poupon MF.
    Clin Cancer Res; 2000 May 15; 6(5):2075-86. PubMed ID: 10815935
    [Abstract] [Full Text] [Related]

  • 17. Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.
    Tsai CM, Chang KT, Perng RP, Mitsudomi T, Chen MH, Kadoyama C, Gazdar AF.
    J Natl Cancer Inst; 1993 Jun 02; 85(11):897-901. PubMed ID: 8098377
    [Abstract] [Full Text] [Related]

  • 18. Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.
    Sobottka SB, Berger MR.
    Cancer Chemother Pharmacol; 1992 Jun 02; 30(5):385-93. PubMed ID: 1505077
    [Abstract] [Full Text] [Related]

  • 19. Effect of CPT-11 in combination with other anticancer agents in lung cancer cells.
    Pei XH, Nakanishi Y, Takayama K, Bai F, Kawasaki M, Tsuruta N, Mizuno K, Hara N.
    Anticancer Drugs; 1997 Mar 02; 8(3):231-7. PubMed ID: 9095327
    [Abstract] [Full Text] [Related]

  • 20. Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.
    Jensen PB, Christensen IJ, Sehested M, Hansen HH, Vindeløv L.
    Br J Cancer; 1993 Feb 02; 67(2):311-20. PubMed ID: 8094293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.